Skip to main content
. Author manuscript; available in PMC: 2015 Sep 14.
Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2012 Jan 18;94(3):141–146. doi: 10.1002/bdra.22883

Table 1.

Infant and maternal characteristics of spina bifida and anencephaly cases and controls, National Birth Defects Prevention Study, 1997–2007

Spina Bifidaa (N=836) Anencephalya (N=403) Controlsa (N=8,494)

Exposure N (%) P-valueb N (%) P-valueb N (%)
Infant factors:
 Sex
  Male 414 (50.1) 0.69 163 (45.2) 0.03 4,314 (50.8)
  Female 412 (49.9) 198 (54.8) 4,172 (49.2)
 Family history of NTDsc
  Yes 19 (2.3) <0.001 10 (2.5) <0.001 32 (0.4)
  No 817 (97.7) 393 (97.5) 8,462 (99.6)
Maternal factors:
 Race/ethnicity
  Non-Hispanic White 451 (54.1) <0.001 194 (48.4) <0.001 4,958 (58.6)
  Non-Hispanic Black 65 (7.8) 28 (7.0) 935 (11.0)
  Hispanic 265 (31.8) 144 (35.9) 1,918 (22.7)
  Other 53 (6.4) 35 (8.7) 653 (7.7)
 BMI (kg/m2)
  Underweight (<18.5) 28 (3.6) <0.001 24 (6.4) 0.30 438 (5.4)
  Normal (18.5–24.9) 356 (46.0) 191 (50.8) 4,474 (55.1)
  Overweight (25.0–29.9) 185 (23.9) 87 (23.1) 1,854 (22.8)
  Obese (≥30) 205 (26.5) 74 (19.7) 1,360 (16.7)
 Folic acid supplementationd,e
  Yes 409 (49.1) 0.36 208 (51.6) 0.73 4,293 (50.7)
  No 424 (50.9) 195 (48.4) 4,167 (49.3)
 Low dietary folate intake (daily μg)
  Quartile 4 (>720.5) 193 (23.3) 0.06 92 (22.9) <0.001 2,107 (25.0)
  Quartile 3 (496.0–720.5) 201 (24.3) 75 (18.7) 2,106 (25.0)
  Quartile 2 (333.7–495.9) 202 (24.4) 103 (25.6) 2,107 (25.0)
  Quartile 1(≤333.6) 232 (28.0) 132 (32.8) 2,107 (25.0)
 Anticonvulsant usee
  Yes 16 (1.9) <0.001 6 (1.5) 0.14 65 (0.8)
  No 816 (98.1) 393 (98.5) 8,369 (99.2)
 Diabetes before index pregnancy
  Yes 3 (0.4) 0.63 8 (2.0) 0.005 51 (0.6)
  No 831 (99.6) 395 (98.0) 8,423 (99.4)
 Gestational diabetes during index pregnancy
  Yes 43 (5.2) 0.13 13 (3.2) 0.41 343 (4.0)
  No 791 (94.8) 390 (96.8) 8,131 (96.0)
 Hot tub or sauna usee
  Yes 40 (4.9) 0.25 24 (6.1) 0.84 488 (5.9)
  No 780 (95.1) 370 (93.9) 7,852 (94.1)
a

Characteristic totals may not equal case group totals due to missing data

b

P-value from chi-square test (or Fisher exact test when an expected cell count was <5) of the comparison with controls

c

In first or second-degree relative

d

Any use of folic acid, multivitamin, or prenatal vitamin supplementation

e

During the month before pregnancy and the first month of pregnancy (B1-P1)